Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,906 | 304 | 83.9% |
| Travel and Lodging | $787.11 | 3 | 13.5% |
| Education | $105.80 | 3 | 1.8% |
| Debt forgiveness | $45.00 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $1,064 | 16 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $733.95 | 52 | $0 (2019) |
| Amgen Inc. | $570.35 | 32 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $331.70 | 28 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $290.42 | 19 | $0 (2019) |
| PFIZER INC. | $284.19 | 25 | $0 (2019) |
| Gilead Sciences, Inc. | $229.57 | 21 | $0 (2019) |
| Astellas Pharma US Inc | $204.44 | 7 | $0 (2018) |
| Edwards Lifesciences Corporation | $197.49 | 7 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $189.27 | 12 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $60.30 | 2 | ABIOMED ($45.51) |
| 2023 | $143.82 | 4 | Edwards Lifesciences Corporation ($143.82) |
| 2022 | $91.58 | 2 | ZOLL Circulation Inc ($46.58) |
| 2019 | $928.58 | 55 | Amgen Inc. ($161.32) |
| 2018 | $2,790 | 119 | Abbott Laboratories ($1,005) |
| 2017 | $1,829 | 129 | Janssen Pharmaceuticals, Inc ($273.72) |
All Payment Transactions
311 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 05/02/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $45.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/03/2023 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $13.07 | General |
| 09/01/2023 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $93.76 | General |
| 09/01/2023 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $4.32 | General |
| 06/09/2023 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $32.67 | General |
| 03/16/2022 | ZOLL Circulation Inc | Temperature Management System (Device), Catheter, Temperature Management System Start-Up Kit | Food and Beverage | Cash or cash equivalent | $46.58 | General |
| Category: Temperature Management | ||||||
| 01/06/2022 | Baxter Healthcare | — | Debt forgiveness | In-kind items and services | $45.00 | General |
| 08/28/2019 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological) | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 08/23/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/21/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: Cardiology | ||||||
| 08/13/2019 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/08/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/07/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Hypertriglyceridemia | ||||||
| 08/05/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.69 | General |
| Category: Cardiovascular | ||||||
| 08/02/2019 | Smith+Nephew, Inc. | Santyl (Drug), REGRANEX | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Pharma Product | ||||||
| 07/30/2019 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Cardiology | ||||||
| 07/29/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Hypertriglyceridemia | ||||||
| 07/26/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/18/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.27 | General |
| Category: Cardiovascular | ||||||
| 07/16/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardiology | ||||||
| 07/15/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/12/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.53 | General |
| 07/12/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/09/2019 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Transcatheter Heart Valves | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,330 | 1,857 | $530,955 | $99,666 |
| 2022 | 19 | 1,234 | 1,744 | $469,222 | $105,816 |
| 2021 | 21 | 1,405 | 2,138 | $530,744 | $122,423 |
| 2020 | 22 | 1,410 | 2,307 | $504,375 | $131,640 |
All Medicare Procedures & Services
90 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 113 | 117 | $71,253 | $15,647 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 123 | 187 | $53,240 | $15,553 | 29.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 280 | 291 | $177,219 | $14,451 | 8.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 42 | 42 | $49,140 | $13,522 | 27.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 131 | 139 | $28,225 | $8,442 | 29.9% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 42 | 84 | $49,980 | $8,035 | 16.1% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 40 | 160 | $19,200 | $6,735 | 35.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 41 | $7,380 | $2,401 | 32.5% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 13 | 13 | $8,255 | $2,300 | 27.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 196 | 236 | $15,340 | $2,292 | 14.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $9,600 | $2,090 | 21.8% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 42 | 42 | $10,500 | $1,985 | 18.9% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 19 | 194 | $5,820 | $1,366 | 23.5% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 16 | 16 | $10,240 | $1,241 | 12.1% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 41 | 44 | $3,036 | $818.29 | 27.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 45 | 87 | $1,469 | $723.74 | 49.3% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 13 | 13 | $2,717 | $501.28 | 18.4% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 29 | 29 | $1,711 | $463.10 | 27.1% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 28 | 28 | $1,092 | $294.97 | 27.0% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 14 | 14 | $840.00 | $244.41 | 29.1% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 12 | 12 | $3,348 | $213.60 | 6.4% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 14 | 14 | $700.00 | $190.12 | 27.2% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 14 | 14 | $490.00 | $119.31 | 24.3% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 16 | 16 | $160.00 | $37.92 | 23.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 231 | 298 | $81,170 | $25,319 | 31.2% |
About Dr. Christopher Nardone, MD
Dr. Christopher Nardone, MD is a Cardiovascular Disease healthcare provider based in Fayetteville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1104825199.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Nardone, MD has received a total of $5,844 in payments from pharmaceutical and medical device companies, with $60.30 received in 2024. These payments were reported across 311 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($4,906).
As a Medicare-enrolled provider, Nardone has provided services to 5,379 Medicare beneficiaries, totaling 8,046 services with total Medicare billing of $459,545. Data is available for 4 years (2020–2023), covering 90 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Fayetteville, NY
- Active Since 07/20/2005
- Last Updated 09/16/2019
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1104825199
Products in Payments
- Mitra Clip system (Device) $920.40
- XARELTO (Drug) $733.95
- Corlanor (Drug) $513.72
- ENTRESTO (Drug) $331.70
- ELIQUIS (Drug) $314.11
- PRADAXA (Drug) $275.90
- BRILINTA (Drug) $192.30
- LifeVest (Device) $184.22
- Adempas (Drug) $163.04
- Impella (Device) $160.97
- Definity (Drug) $146.59
- PRALUENT ALIROCUMAB INJECTION (Biological) $141.67
- PRALUENT (Drug) $112.22
- Vascepa (Drug) $108.75
- Amplia MRI (Device) $97.17
- MULTAQ (Drug) $77.05
- CHANTIX (Drug) $66.23
- BYSTOLIC (Drug) $56.91
- Repatha (Biological) $56.63
- LEXISCAN (Drug) $54.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Fayetteville
Andrew Darlington, Do, DO
Cardiovascular Disease — Payments: $1.0M
Frank Fedele, Md, MD
Cardiovascular Disease — Payments: $27,524
Yang Yang
Cardiovascular Disease — Payments: $20,941
Dr. Shaun Senter, Md, MD
Cardiovascular Disease — Payments: $16,513
Dr. Michael Miller, Md, MD
Cardiovascular Disease — Payments: $15,493
Sirisha Reddy, Md, MD
Cardiovascular Disease — Payments: $10,475